Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
After finishing at $1.55 in the prior trading day, Macrogenics Inc (NASDAQ: MGNX) closed at $1.52, down -1.94%. In other words, the price has decreased by -$1.94 from its previous closing price. On the day, 0.95 million shares were traded.
Ratios:
Our goal is to gain a better understanding of MGNX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.11 and its Current Ratio is at 3.28. In the meantime, Its Debt-to-Equity ratio is 0.47 whereas as Long-Term Debt/Eq ratio is at 0.41.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 15 ’25 when Smith Beth Ann sold 423 shares for $2.56 per share. The transaction valued at 1,083 led to the insider holds 9,532 shares of the business.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.62 while its Price-to-Book (P/B) ratio in mrq is 1.21.
Stock Price History:
Over the past 52 weeks, MGNX has reached a high of $5.77, while it has fallen to a 52-week low of $0.99. The 50-Day Moving Average of the stock is 2.30%, while the 200-Day Moving Average is calculated to be -44.16%.
Shares Statistics:
A total of 63.09M shares are outstanding, with a floating share count of 57.94M. Insiders hold about 8.16% of the company’s shares, while institutions hold 80.39% stake in the company.
